Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
Clinical trial NCT04906733 · UNKNOWN
Trial details
- NCT number
- NCT04906733
- Sponsor
- D1 Medical Technology (Shanghai) Co., Ltd, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-15
- Primary completion
- 2023-06-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.